PCM
MRK icon

Penserra Capital Management’s Merck MRK Stock Holding History

Penserra Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Sell
1,753
-9,218
-84% -$1.06M ﹤0.01% 664
2025
Q4 		$1.15M Buy
10,971
+9,000
+457% +$845K 0.01% 411
2025
Q3 		$164K Buy
1,971
+105
+6% +$8.65K ﹤0.01% 725
2025
Q2 		$147K Sell
1,866
-355
-16% -$28.2K ﹤0.01% 681
2025
Q1 		$198K Sell
2,221
-6,314
-74% -$590K ﹤0.01% 739
2024
Q4 		$848K Buy
8,535
+6,344
+290% +$654K 0.02% 450
2024
Q3 		$248K Sell
2,191
-1,012,227
-100% -$120M 0.01% 673
2024
Q2 		$126M Buy
1,014,418
+228,418
+29% +$29.4M 1.59% 13
2024
Q1 		$104M Sell
786,000
-87,295
-10% -$10.8M 1.3% 19
2023
Q4 		$95.2M Sell
873,295
-218,074
-20% -$22.6M 1.79% 16
2023
Q3 		$112M Sell
1,091,369
-144,292
-12% -$15.6M 2.32% 14
2023
Q2 		$143M Buy
1,235,661
+468,262
+61% +$53.2M 2.82% 10
2023
Q1 		$81.6M Sell
767,399
-460,813
-38% -$49.8M 1.69% 18
2022
Q4 		$136M Buy
1,228,212
+238,981
+24% +$24.4M 2.99% 2
2022
Q3 		$85.2M Buy
989,231
+291,569
+42% +$26M 2.42% 8
2022
Q2 		$63.6M Buy
697,662
+381,079
+120% +$33.8M 1.73% 12
2022
Q1 		$26M Buy
+316,583
New +$25M 0.62% 38
2020
Q4 		– Sell
-40,309
Closed -$3.19M – 1094
2020
Q3 		$3.19M Buy
40,309
+23,686
+142% +$1.86M 0.12% 167
2020
Q2 		$1.23M Sell
16,623
-1,939
-10% -$146K 0.06% 227
2020
Q1 		$1.36M Sell
18,562
-17,422
-48% -$1.37M 0.09% 208
2019
Q4 		$3.12M Buy
35,984
+11,973
+50% +$983K 0.2% 139
2019
Q3 		$1.93M Sell
24,011
-4,740
-16% -$380K 0.16% 117
2019
Q2 		$2.3M Buy
28,751
+1,371
+5% +$105K 0.18% 104
2019
Q1 		$2.06M Buy
27,380
+8,973
+49% +$671K 0.16% 104
2018
Q4 		$1.34M Buy
+18,407
New +$1.3M 0.13% 167
2017
Q3 		– Sell
-7,635
Closed -$466K – 576
2017
Q2 		$466K Buy
7,635
+3,799
+99% +$231K 0.17% 101
2017
Q1 		$232K Buy
3,836
+2,557
+200% +$155K 0.02% 172
2016
Q4 		$71K Buy
+1,279
New +$74.9K 0.01% 362

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Penserra Capital Management's MRK Position: Q1 2026 in Review

Penserra Capital Management reduced its Merck (MRK) stake by 84% in Q1 2026, selling an estimated $1.06M and leaving 1,753 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Penserra Capital Management first reported a position in MRK in Q4 2016 and has held it in 28 quarters since. The position peaked at $143M in Q2 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Penserra Capital Management held 1,753 shares of Merck worth $209K as of Q1 2026.
  • Penserra Capital Management sold 9,218 Merck shares in Q1 2026, an estimated $1.06M.
  • Merck made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #664 holding.
  • Penserra Capital Management first reported a position in Merck in Q4 2016 and has held it in 28 quarters since.
  • Penserra Capital Management's Merck position peaked at $143M in Q2 2023.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.